Michelle Silver
机构: Washington University School of Medicine
每年引用次数
引用次数
引用: 1,899
H-指数: 22
I10-指数 : 27
出版物: 60
Abstract P4-06-01: Provider practice and compliance with NCCN clinical guidelines forBRCA1/2testing: Findings from Dr. Susan Love Research Foundation's The Health of Women (HOW) StudyTM
MC Roberts , J Loud , WMP Klein , MI Silver
Cancer Research 78
2018
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states
T Shato , S Humble , A Anandarajah , A Barnette
Vaccine 41 ( 25) 3772 -3781
5
2023
HPV detection at menopause
PE Gravitt , AF Rositch , MI Silver
Obesity and Human Papillomavirus Infection in Perimenopausal Women
S.-H. Liu , A. F. Rositch , R. P. Viscidi , M. I. Silver
The Journal of Infectious Diseases 208 ( 7) 1071 -1080
14
2013
The promise and challenges of dissemination and implementation research
MICHELLE SILVER , GRAHAM A COLDITZ , KAREN M EMMONS
Dissemination and Implementation Research in Health: Translating Science to Practice 1 -1
2
2023
Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach.
Valerie A. Paz-Soldan , Laura Nervi , Megan Huchko , Silvina Arrossi
Preventive Medicine 144 106322 -106322
13
2021
Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) Positivity in Cervical Cancer Screening of Women in a Peri-Urban Area in Andhra Pradesh, India
Haripriya Vedantham , Michelle I. Silver , B. Kalpana , C. Rekha
Cancer Epidemiology, Biomarkers & Prevention 19 ( 5) 1373 -1380
46
2010
Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis
Michelle I. Silver , Jeff Andrews , Charles K. Cooper , Julia C. Gage
Obstetrics & Gynecology 132 ( 3) 725 -735
13
2018
The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
Michelle I. Silver , Mark Schiffman , Barbara Fetterman , Nancy E. Poitras
Cancer 122 ( 23) 3682 -3686
13
2016
Cancer screening: health impact, prevalence, correlates, and interventions
Elizabeth A. Sarma , Michelle I. Silver , Sarah C. Kobrin , Pamela M. Marcus
Psychology & Health 34 ( 9) 1036 -1072
8
2019
Cervical Cancer Screening in Older Women: New Evidence and Knowledge Gaps
Anne F. Rositch , Michelle I. Silver , Patti E. Gravitt
PLoS Medicine 11 ( 1) e1001586
11
2014
Exacerbating disparities?: Cervical cancer screening and HPV vaccination.
Michelle I. Silver , Sarah Kobrin
Preventive Medicine 130 105902
3
2020
Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study®.
Michelle I. Silver , William Klein , Goli Samimi , Lori Minasian
Breast Cancer Research and Treatment 173 ( 3) 719 -726
3
2019
A Cohort Effect of the Sexual Revolution May Be Masking an Increase in Human Papillomavirus Detection at Menopause in the United States
Patti E. Gravitt , Anne F. Rositch , Michelle I. Silver , Morgan A. Marks
The Journal of Infectious Diseases 207 ( 2) 272 -280
71
2013
A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.
Nicolas Wentzensen , Joan Walker , Katie Smith , Michael A. Gold
American Journal of Obstetrics and Gynecology 218 ( 6)
9
2018
Differences in Family Health History Knowledge Among Bisexual and Lesbian Women.
Megan C. Roberts , Melinda Krakow , Christopher W. Wheldon , Michelle I. Silver
LGBT health 6 ( 3) 134 -137
1
2019
The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women.
Anne F. Rositch , Michelle I. Silver , Anne Burke , Raphael Viscidi
Journal of Lower Genital Tract Disease 17 ( 1) 38 -47
17
2013
Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years
Michelle I. Silver , Julia C. Gage , Mark Schiffman , Barbara Fetterman
Cancer Prevention Research 11 ( 3) 165 -170
14
2018
Biomarkers for Cervical Cancer Prevention Programs: The Long and Winding Road From Discovery to Clinical Use.
Nicolas Wentzensen , Michelle I. Silver
Journal of Lower Genital Tract Disease 20 ( 3) 191 -194
4
2016